Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001415889-23-009406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-07 | 2023-06-05+ | OLMA | Harmon Cyrus | Dir | S - Sale | $6.17 | -10.0K | 1.05M | -0.9% | -$61.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-05 | S | D | 5,000 | $6.05 | 1,053,714 | D | — | — | (F1) The weighted average sale price for the transaction reported was $6.045 and the range of prices were between $5.96 and $6.10. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. (F2) Includes 7,568 shares acquired under the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-06-06 | S | D | 5,000 | $6.30 | 1,048,714 | D | — | — | (F3) The weighted average sale price for the transaction reported was $6.295, and the range of prices were between $6.24 and $6.37. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |